Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a new 'Last Update Posted (Estimated)' label in place of the previous 'Last Update Posted'.SummaryDifference0.0%

- Check15 days agoChange DetectedExpanded Access information and documentation were added to the study record. A list of 11 participating locations across several states was included, providing details on where the trial is conducted.SummaryDifference4%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page revision label changes from v3.2.0 to v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoval of the government funding notice banner; core study information and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedNo additions or deletions detected. The page content and layout appear unchanged between screenshots.SummaryDifference0.4%

- Check94 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.